Publicacións en colaboración con investigadores/as de London School of Hygiene & Tropical Medicine (92)

2024

  1. Evaluating the implementation of a hypertension program based on mHealth and community pharmacies integration to primary care centers at a municipality level in Argentina during the COVID-19 pandemic

    Frontiers in Health Services, Vol. 4

2023

  1. Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: An implementation study

    BMJ Open, Vol. 13, Núm. 1

  2. The effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis: Results from the global SECURE-AD registry

    Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 2, pp. 365-381

2022

  1. A Bayesian hierarchical model with integrated covariate selection and misclassification matrices to estimate neonatal and child causes of death

    Journal of the Royal Statistical Society. Series A: Statistics in Society, Vol. 185, Núm. 4, pp. 2097-2120

  2. A systematic review of statistical methodology used to evaluate progression of chronic kidney disease using electronic healthcare records

    PLoS ONE, Vol. 17, Núm. 7 July

  3. Association between practice coding of chronic kidney disease (CKD) in primary care and subsequent hospitalisations and death: a cohort analysis using national audit data

    BMJ Open, Vol. 12, Núm. 10

  4. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 2, pp. 106-115

  5. Hidden heterogeneity: Uncovering patterns of adherence in microbicide trials for HIV prevention

    PLoS ONE, Vol. 17, Núm. 5 May

  6. High sensitivity troponin and COVID-19 outcomes

    Acta Cardiologica, Vol. 77, Núm. 1, pp. 81-88

  7. Novel multimorbidity clusters in people with eczema and asthma: a population-based cluster analysis

    Scientific Reports, Vol. 12, Núm. 1

  8. Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease

    Circulation, Vol. 146, Núm. 3, pp. 240-248

2021

  1. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

    JACC: Clinical Electrophysiology, Vol. 7, Núm. 2, pp. 210-222

  2. Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. A post hoc analysis of a clinical trial

    Microorganisms, Vol. 9, Núm. 4

  3. Clinical outcomes in a primary-level noncommunicable disease programme for Syrian refugees and the host population in Jordan: A cohort analysis using routine data

    PLoS Medicine, Vol. 18, Núm. 1

  4. Efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: TXT2HEART Colombia randomized controlled trial

    JMIR mHealth and uHealth, Vol. 9, Núm. 7

  5. Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets

    Journal of Pharmaceutical Policy and Practice, Vol. 14, Núm. 1

  6. Feasibility of evaluation of the natural history of kidney disease in the general population using electronic healthcare records

    Clinical Kidney Journal, Vol. 14, Núm. 6, pp. 1603-1609

2020

  1. Bayesian hierarchical methods in the detection of potentially teratogenic first-trimester medications

    Pharmacoepidemiology and Drug Safety, Vol. 29, Núm. 3, pp. 337-346

  2. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic

    British Journal of Dermatology

  3. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema

    British Journal of Dermatology, Vol. 182, Núm. 6, pp. 1423-1429